PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression.

Abstract

As there is growing evidence for the tumor microenvironment's role in tumorigenesis, we investigated the role of fibroblast-expressed kinases in triple-negative breast cancer (TNBC). Using a high-throughput kinome screen combined with 3D invasion assays, we identified fibroblast-expressed PIK3Cδ (f-PIK3Cδ) as a key regulator of cancer progression. Although PIK3Cδ was expressed in primary fibroblasts derived from TNBC patients, it was barely detectable in breast cancer (BC) cell lines. Genetic and pharmacological gain- and loss-of-function experiments verified the contribution of f-PIK3Cδ in TNBC cell invasion. Integrated secretomics and transcriptomics analyses revealed a paracrine mechanism via which f-PIK3Cδ confers its protumorigenic effects. Inhibition of f-PIK3Cδ promoted the secretion of factors, including PLGF and BDNF, that led to upregulation of NR4A1 in TNBC cells, where it acts as a tumor suppressor. Inhibition of PIK3Cδ in an orthotopic BC mouse model reduced tumor growth only after inoculation with fibroblasts, indicating a role of f-PIK3Cδ in cancer progression. Similar results were observed in the MMTV-PyMT transgenic BC mouse model, along with a decrease in tumor metastasis, emphasizing the potential immune-independent effects of PIK3Cδ inhibition. Finally, analysis of BC patient cohorts and TCGA data sets identified f-PIK3Cδ (protein and mRNA levels) as an independent prognostic factor for overall and disease-free survival, highlighting it as a therapeutic target for TNBC.

• Authors: Teresa Gagliano, Kalpit Shah, Sofia Gargani, Liyan Lao, Mansour Alsaleem, Jianing Chen, Vasileios Ntafis, Penghan Huang, Angeliki Ditsiou, Viviana Vella, Kritika Yadav, Kamila Bienkowska, Giulia Bresciani, Kai Kang, Leping Li, Philip Carter, Graeme Benstead-Hume, Timothy O'Hanlon, Michael Dean, Frances Mg Pearl, Soo-Chin Lee, Emad A Rakha, Andrew R Green, Dimitris L Kontoyiannis, Erwei Song, Justin Stebbing, Georgios Giamas
• Journal: The Journal of clinical investigation (J Clin Invest) Vol. 130 Issue 6 Pg. 3188-3204 (06 01 2020) ISSN: 1558-8238 [Electronic] United States
• PMID: 32125284 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)

Chemical References

• Neoplasm Proteins
• Class I Phosphatidylinositol 3-Kinases
• PIK3CD protein, human

Topics

• Animals
• Class I Phosphatidylinositol 3-Kinases (biosynthesis, genetics)
• Female
• Fibroblasts (enzymology, pathology)
• Gene Expression Regulation, Enzymologic
• Gene Expression Regulation, Neoplastic
• Heterografts
• Humans
• Mice
• Mice, Transgenic
• Neoplasm Invasiveness
• Neoplasm Metastasis
• Neoplasm Proteins (biosynthesis, genetics)
• Neoplasm Transplantation
• Triple Negative Breast Neoplasms (enzymology, genetics, pathology)